As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January ...

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Stay ahead in 2025 with the latest biotech deals. Discover key collaborations, M&A, and strategic moves shaping the ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

Discover ITM and its cancer candidate ITM-11 as it brings one of the first big wins the radiopharmaceutical sector awaits.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.